Cargando…

Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries

Patients are recognized as important players in the pharmacovigilance system. This study aims to describe and compare the characteristics of patient reporting systems, reporting forms, awareness raising-activities, and the statistics related to patient reporting in the selected countries. Fifteen co...

Descripción completa

Detalles Bibliográficos
Autores principales: Worakunphanich, Wiwan, Youngkong, Sitaporn, Suwankesawong, Wimon, Anderson, Claire, Thavorncharoensap, Montarat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028008/
https://www.ncbi.nlm.nih.gov/pubmed/35457318
http://dx.doi.org/10.3390/ijerph19084447
_version_ 1784691510250307584
author Worakunphanich, Wiwan
Youngkong, Sitaporn
Suwankesawong, Wimon
Anderson, Claire
Thavorncharoensap, Montarat
author_facet Worakunphanich, Wiwan
Youngkong, Sitaporn
Suwankesawong, Wimon
Anderson, Claire
Thavorncharoensap, Montarat
author_sort Worakunphanich, Wiwan
collection PubMed
description Patients are recognized as important players in the pharmacovigilance system. This study aims to describe and compare the characteristics of patient reporting systems, reporting forms, awareness raising-activities, and the statistics related to patient reporting in the selected countries. Fifteen countries (eight Western countries and seven Asian countries) were purposively selected. A questionnaire survey was distributed to national pharmacovigilance authorities in those countries. Nine countries (five Western countries and four Asian countries) returned the questionnaire. A review of the websites of national pharmacovigilance centres was conducted. The proportion of patient reports in the selected Western countries ranged from 57.83% to 14.37%, while it was accounted for less than 1% in the selected Asian countries. Currently, patients in all nine countries can report adverse drug reactions online via a website. The number of clicks from the national pharmacovigilance website to reach the online reporting form range from one to five clicks. Countries with higher patient reporting rates seemed to share the following characteristics; provision of feedback, engagement with patient organizations, and implementation of several activities to raise the awareness of the general public on the importance of pharmacovigilance. To increase the number of patient reports, the strengths of each country’s system should be adopted.
format Online
Article
Text
id pubmed-9028008
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90280082022-04-23 Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries Worakunphanich, Wiwan Youngkong, Sitaporn Suwankesawong, Wimon Anderson, Claire Thavorncharoensap, Montarat Int J Environ Res Public Health Article Patients are recognized as important players in the pharmacovigilance system. This study aims to describe and compare the characteristics of patient reporting systems, reporting forms, awareness raising-activities, and the statistics related to patient reporting in the selected countries. Fifteen countries (eight Western countries and seven Asian countries) were purposively selected. A questionnaire survey was distributed to national pharmacovigilance authorities in those countries. Nine countries (five Western countries and four Asian countries) returned the questionnaire. A review of the websites of national pharmacovigilance centres was conducted. The proportion of patient reports in the selected Western countries ranged from 57.83% to 14.37%, while it was accounted for less than 1% in the selected Asian countries. Currently, patients in all nine countries can report adverse drug reactions online via a website. The number of clicks from the national pharmacovigilance website to reach the online reporting form range from one to five clicks. Countries with higher patient reporting rates seemed to share the following characteristics; provision of feedback, engagement with patient organizations, and implementation of several activities to raise the awareness of the general public on the importance of pharmacovigilance. To increase the number of patient reports, the strengths of each country’s system should be adopted. MDPI 2022-04-07 /pmc/articles/PMC9028008/ /pubmed/35457318 http://dx.doi.org/10.3390/ijerph19084447 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Worakunphanich, Wiwan
Youngkong, Sitaporn
Suwankesawong, Wimon
Anderson, Claire
Thavorncharoensap, Montarat
Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries
title Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries
title_full Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries
title_fullStr Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries
title_full_unstemmed Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries
title_short Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries
title_sort comparison of patient adverse drug reaction reporting systems in nine selected countries
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028008/
https://www.ncbi.nlm.nih.gov/pubmed/35457318
http://dx.doi.org/10.3390/ijerph19084447
work_keys_str_mv AT worakunphanichwiwan comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries
AT youngkongsitaporn comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries
AT suwankesawongwimon comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries
AT andersonclaire comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries
AT thavorncharoensapmontarat comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries